Jobs — and national identity — top French concerns over the news that pharmaceutical company Sanofi plans to sell 50% of ...

Unions in France are planning a walkout over the planned sale of the pharmaceutical company that makes popular painkiller brand Doliprane to a US investment fund Employees at French pharmaceutical ...

French pharmaceutical company Sanofi's plan ... Could France one day run out of Doliprane, the beloved paracetamol painkiller currently produced in Lisieux, Normandy, and Compiègne, north of ...

Doliprane is the brand under which healthcare giant Sanofi sells paracetamol, a non-opioid analgesic for the alleviation of mild to moderate pain, and of fever. In French pharmacies, the brand's ...

Read more French government stuck in Doliprane dilemma A series of guarantees have been listed in this agreement. The first concerns the future of the Lisieux and Compiègne (north of Paris ...

PARIS (Reuters) - The French government is seeking job guarantees from drugmaker Sanofi regarding its Doliprane production ...

The subsidiary makes household-name drugs including Doliprane branded paracetamol -- whose yellow boxes dominate the French market. Under pressure, Prime Minister Michel Barnier's minority ...

The French government needs guarantees from drugmaker Sanofi (SASY.PA), opens new tab that production of its popular Doliprane painkiller will stay in France to allow the sale of its consumer ...

The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane painkiller will stay in France to allow the sale of its consumer health branch to go ahead, ...

Doliprane is the brand under which healthcare giant Sanofi sells paracetamol, a non-opioid analgesic for the alleviation of mild to moderate pain, and of fever. In French pharmacies, the brand's ...